Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Narrative (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Narrative (Details)
12 Months Ended
Sep. 01, 2022
Aug. 31, 2022
USD ($)
plan
$ / shares
shares
Oct. 22, 2021
USD ($)
$ / shares
shares
Aug. 31, 2022
USD ($)
plan
$ / shares
shares
Aug. 31, 2021
USD ($)
$ / shares
shares
Aug. 31, 2020
segment
Oct. 21, 2021
shares
Oct. 19, 2021
shares
Sep. 01, 2021
USD ($)
Concentration Risk [Line Items]                  
Contract with customer, term       12 months          
Contract with customer, cancellation period       30 days          
Unbilled accounts receivable   $ 2,105,000   $ 2,105,000 $ 2,741,000        
Number of reportable segments | segment           1      
Cash in excess of amounts insured by the FDIC   614,900   $ 614,900          
Property, plant and equipment, useful life       5 years          
Research and development expense       $ 4,100,000 6,800,000        
Lease Liability   4,294,924   4,294,924          
Impaired asset expense       4,004,000 0        
ROU asset impairment   3,866,802   3,851,000          
Workers' compensation, claim responsibility per occurrence   500,000   500,000          
Workers' compensation asset, current   0   0 155,000        
Workers' compensation asset, noncurrent   0   0 386,000        
Accrued workers’ compensation costs   567,000   567,000 663,000        
Accrued workers’ compensation costs   1,227,000   1,227,000 1,646,000        
Short term liabilities   1,400,000   1,400,000          
Long term liabilities   3,300,000   3,300,000          
Short term assets   0   0          
Long term assets   $ 0   0          
Advertising costs       $ 2,500,000 $ 2,600,000        
Share based compensation arrangement by share based payment award number of stock-based compensation plans | plan   1   1          
Weighted average number of common shares outstanding for the earnings per share increased | shares       8,600,000 11,827,570        
Exercise price of warrants (in dollars per share) | $ / shares   $ 78   $ 78 $ 384        
Class of warrant or right, outstanding (in shares) | shares   522,786   522,786 95,921        
Common stock, shares, transferred (in shares) | shares     15,000            
Temporary equity, carrying amount, attributable to parent   $ 116,969,000 $ 116,725,000 $ 116,969,000 $ 0        
Remeasurement of IHC temporary equity     13,000,000 13,675,000          
Deferred offering costs – SPACs (See Note 5 and 6)   $ 0   0 48,261,000        
SPAC related offering costs paid       $ 3,663,000 789,000        
Subsequent Event                  
Concentration Risk [Line Items]                  
Stock split conversion ratio 0.01                
Industrial Human Capital, Inc.                  
Concentration Risk [Line Items]                  
Remeasurement of IHC temporary equity     9,500,000            
Deferred offering costs – SPACs (See Note 5 and 6)     $ 9,500,000   $ 9,800,000        
Industrial Human Capital, Inc.                  
Concentration Risk [Line Items]                  
Variable interest entity, qualitative or quantitative information, ownership percentage       15.00%          
Common stock, shares, owned (in shares) | shares   2,110,000 2,110,000 2,110,000     2,125,000    
SPAC related offering costs paid     $ 3,500,000 $ 3,500,000          
IPO | Industrial Human Capital, Inc.                  
Concentration Risk [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares) | shares       11,500,000          
Proceeds from issuance initial public offering     115,000,000            
Assets held-in-trust   $ 1,700,000 $ 1,725,000 $ 1,700,000          
Price per share (in dollars per share) | $ / shares     $ 10.00            
Sale of stock, number of common shares issued per unit (in shares) | shares     1         1  
Sale of stock, number of warrants issued per unit (in shares) | shares     1            
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares     1         1  
Exercise price of warrants (in dollars per share) | $ / shares     $ 11.50            
Business combination, initial business combination consummation period     12 months            
Redeemable noncontrolling interest, equity, common, redemption percentage     100.00%            
IPO | Industrial Human Capital, Inc. | Placement Warrants                  
Concentration Risk [Line Items]                  
Class of warrant or right, outstanding (in shares) | shares     4,639,102            
Sale of warrants (in dollars per share) | $ / shares     $ 1.00            
Aggregate purchase price     $ 4,639,102            
Accounting Standards Update 2018-11                  
Concentration Risk [Line Items]                  
Lease Liability                 $ 7,700,000
Minimum | Software Development                  
Concentration Risk [Line Items]                  
Property, plant and equipment, useful life       3 years          
Maximum | Software Development                  
Concentration Risk [Line Items]                  
Property, plant and equipment, useful life       5 years          
Two Clients | Customer Concentration Risk | Revenue from Contract with Customer Benchmark                  
Concentration Risk [Line Items]                  
Concentration of credit risk percent         10.00%        
Five Clients | Customer Concentration Risk | Accounts Receivable                  
Concentration Risk [Line Items]                  
Concentration of credit risk percent       96.00%          
Four Clients | Customer Concentration Risk | Accounts Receivable                  
Concentration Risk [Line Items]                  
Concentration of credit risk percent         94.00%